TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts6366
Avg. Estimate-0.52-0.46-2.09-1.53
Low Estimate-0.6-0.63-2.26-2.09
High Estimate-0.41-0.3-1.76-0.96
Year Ago EPS-0.46-0.59-1.91-2.09
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts5166
Avg. Estimate30k40k160k150k
Low EstimateN/A40k80kN/A
High Estimate40k40k200k200k
Year Ago Sales38k38k152k160k
Sales Growth (year/est)-21.10%5.30%5.30%-6.30%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.44-0.44-0.53-0.54
EPS Actual-0.46-0.59-0.59-0.43
Difference-0.02-0.15-0.060.11
Surprise %-4.50%-34.10%-11.30%20.40%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.52-0.46-2.09-1.53
7 Days Ago-0.53-0.48-2.15-2.12
30 Days Ago-0.53-0.48-2.15-2.12
60 Days Ago-0.53-0.5-2.19-1.96
90 Days Ago-0.51-0.48-2.14-1.88
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 Days1125
Up Last 30 Days1125
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTGTXIndustrySectorS&P 500
Current Qtr.-13.00%N/AN/A0.48
Next Qtr.22.00%N/AN/A0.40
Current Year-9.40%N/AN/A0.21
Next Year26.80%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A